BiotechTube
Home/ArrePath/Kevin Krause
KK

Kevin Krause

President and Chief Executive Officer

ArrePath

Therapeutic Areas

Infectious DiseasesRespiratory Medicine

ArrePath Pipeline

DrugIndicationPhase
Novel Antibiotic Class 1Bacterial InfectionsPre-clinical
Novel Antibiotic Class 2Bacterial InfectionsPre-clinical
NTM ProgramNon-Tuberculous Mycobacterial InfectionsPre-clinical
Respiratory Medicine ProgramUndisclosed Respiratory DiseaseDiscovery

Leadership Team at ArrePath

AM
Alita Miller, Ph. D.
Chief Scientific Officer
View full ArrePath profile